Home › Funds › MONARCH CAPITAL MANAGEMENT INC › ABT

MONARCH CAPITAL MANAGEMENT INC position in ABT

ABBOTT LABORATORIES · Health Care

MONARCH CAPITAL MANAGEMENT INC reported holding 55,344 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$5.5M, representing 1.25% of its reported portfolio and ranking #28 among its reported holdings. MONARCH CAPITAL MANAGEMENT INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)55.34K sh
Reported value held$5.47M
Portfolio Weight1.25%
First reportedQ3 2023
Last changeReduce
Updated2026-10-21

Last updated: 2026-10-21 · Source: SEC EDGAR Form 13F-HR

How MONARCH CAPITAL MANAGEMENT INC's ABT position evolved

MONARCH CAPITAL MANAGEMENT INC first disclosed a stake in ABT in Q3 2023 at 57,850 shares (US$5.6M). The position peaked in Q2 2025 at 53,674 shares, worth US$7.3M. Across 13 filings, MONARCH CAPITAL MANAGEMENT INC increased the stake 3 time(s), trimmed it 6 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 55,344 shares valued at US$5.5M — a reduction of -461 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 57.85K $5.60M New
Q4 2023 56.43K $6.21M Reduce
Q1 2024 56.15K $6.38M Reduce
Q2 2024 55.45K $5.76M Reduce
Q3 2024 56.16K $6.40M Add
Q4 2024 56.17K $6.35M Hold
Q1 2025 54.73K $7.26M Reduce
Q2 2025 53.67K $7.30M Reduce
Q3 2025 54.46K $7.29M Add
Q4 2025 54.27K $6.80M Hold
Q1 2026 54.26K $5.57M Hold
Q2 2026 55.80K $5.06M Add
Q3 2026 55.34K $5.47M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has MONARCH CAPITAL MANAGEMENT INC held ABT?

MONARCH CAPITAL MANAGEMENT INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MONARCH CAPITAL MANAGEMENT INC's current position in ABT?

As of Q3 2026, MONARCH CAPITAL MANAGEMENT INC holds 55.34K shares of ABT (ABBOTT LABORATORIES), valued at $5.47M, representing 1.25% of its reported portfolio and ranking #28.

Has MONARCH CAPITAL MANAGEMENT INC been buying or selling ABT?

In the latest 13F filing (Q3 2026), MONARCH CAPITAL MANAGEMENT INC reduced its position in ABT. The position peaked in Q2 2025 at 53.67K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.